Turkey-based food supplement brand Orzax held the groundbreaking ceremony for its new manufacturing facility in the Turkistan "TURAN" Special Economic Zone in Kazakhstan to strengthen its global market footprint.
The ceremony was attended by Governor of Turkistan Region Kosherov Nuralhan Oralbayuly, Orzax Chairman of the Board Pharm. Selman Alimoğlu, Orzax Kazakhstan General Manager Nurettin Aktaş, state representatives, business partners, and members of the press.
Supported by financing from the European Bank for Reconstruction and Development (EBRD) and state incentives, the plant is being constructed on 100 decares of free allocated land. The investment benefits from a 15-year 0% corporate tax rate, VAT exemption, property tax exemptions, social security employer contribution discounts, 0% customs duty on imported machinery and raw materials, and a 30% discount on utility expenses.
Export Roadmap and Financial Targets
Operating under GMP standards, the plant will start with an initial annual capacity of 36 million boxes, eventually scaling to 80 million boxes. Between 85% and 90% of output will be exported across Central Asia, East Asia, Far East Asia, and CIS nations, while 10% to 15% will supply the domestic Kazakh market. Upon reaching full capacity, the plant will employ 500 people directly, with future plans to integrate production lines for pharmaceuticals, cosmetics, and active ingredients.
Executive Statement
Evaluating the strategic investment, Orzax Board Chairman Pharm. Selman Alimoğlu stated:
This facility in Turkistan is one of our most critical strategic moves to increase Orzax’s global competitiveness and profitability. Implemented with a $40 million investment, our facility will start with an initial annual production capacity of 36 million boxes and reach 80 million boxes in the future. In line with our financial targets, we aim for a revenue of $100 million in the first phase; upon completion of our capacity expansions, we will bring this figure to a capacity and export volume of $180 million. Cost-effective energy resources, tax exemptions, and duty-free access to 12 countries offered by Kazakhstan will significantly lower our unit production costs, serving as a primary growth driver for Orzax in global markets.
